TRANSFERRIN RECEPTOR EXPRESSION IN ADENOCARCINOMA OF THE LUNG AS A HISTOPATHOLOGIC INDICATOR OF PROGNOSIS

被引:64
作者
KONDO, K
NOGUCHI, M
MUKAI, K
MATSUNO, Y
SATO, Y
SHIMOSATO, Y
MONDEN, Y
机构
[1] NATL CANC CTR,RES INST,DIV PATHOL,5-1-1 TSUKIJI,CHUO KU,TOKYO 104,JAPAN
[2] UNIV TOKUSHIMA,SCH MED,DEPT SURG 2,TOKUSHIMA 770,JAPAN
关键词
D O I
10.1378/chest.97.6.1367
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Immunohistochemical reactivity with OKT9 (antitransferrin receptor) monoclonal antibody was studied in 58 surgically resected adenocarcinomas of the lung. The cell surface and cytoplasm of the tumor cells were stained in 44 cases (76 percent). The expression of the transferrin receptor (TrfR) in tumor cells was compared with histopathologic prognostic factors, such as TNM factors, degree of histologic differentiation, degree of nuclear atypia, and frequency of mitotic figures. The expression of TrfR showed significant correlation with the degree of histopathologic differentiation (p < 0.025), degree of nuclear atypia (p < 0.025), and frequency of mitotic figures (p < 0.001). However, there was no definite correlation with TNM factors. These results indicate that the expression of the TrfR in pulmonary adenocarcinoma corresponds to the elevated proliferative activity of the tumor cells, and that immunohistochemical reactivity with OKT9 can be used as one of the histopathologic indicators of prognosis of pulmonary adenocarcinoma.
引用
收藏
页码:1367 / 1371
页数:5
相关论文
共 33 条
[1]   NUCLEAR-DNA CONTENT BY CYTOFLUOROMETRY OF STAGE-I ADENOCARCINOMA OF THE LUNG IN RELATION TO POSTOPERATIVE RECURRENCE [J].
ASAMURA, H ;
NAKAJIMA, T ;
MUKAI, K ;
SHIMOSATO, Y .
CHEST, 1989, 96 (02) :312-318
[2]  
BROWN G, 1981, HUM LYMPHOCYTE DIFF, V1, P167
[3]   THE USE OF THE MONOCLONAL-ANTIBODY KI-67 IN THE IDENTIFICATION OF PROLIFERATING CELLS - APPLICATION TO SURGICAL NEUROPATHOLOGY [J].
BURGER, PC ;
SHIBATA, T ;
KLEIHUES, P .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1986, 10 (09) :611-617
[4]   CARCINOMA OF THE LUNG - EVALUATION OF HISTOLOGICAL GRADE AND FACTORS INFLUENCING PROGNOSIS [J].
CHUNG, CK ;
ZAINO, R ;
STRYKER, JA ;
ONEILL, M ;
DEMUTH, WE .
ANNALS OF THORACIC SURGERY, 1982, 33 (06) :599-604
[5]   EXPRESSION OF C-MYC IN NONMALIGNANT AND PREMALIGNANT GASTROINTESTINAL DISORDERS [J].
CICLITIRA, PJ ;
MACARTNEY, JC ;
EVAN, G .
JOURNAL OF PATHOLOGY, 1987, 151 (04) :293-296
[6]   MODULATION OF T-LEUKEMIC-CELL PHENOTYPE WITH PHORBOL ESTER [J].
DELIA, D ;
GREAVES, MF ;
NEWMAN, RA ;
SUTHERLAND, DR ;
MINOWADA, J ;
KUNG, P ;
GOLDSTEIN, G .
INTERNATIONAL JOURNAL OF CANCER, 1982, 29 (01) :23-31
[7]  
DORIA MI, 1988, CANCER, V62, P1939, DOI 10.1002/1097-0142(19881101)62:9<1939::AID-CNCR2820620912>3.0.CO
[8]  
2-N
[9]  
FAULK WP, 1980, LANCET, V2, P390
[10]   TRANSFERRIN RECEPTORS IN HUMAN-TISSUES - THEIR DISTRIBUTION AND POSSIBLE CLINICAL RELEVANCE [J].
GATTER, KC ;
BROWN, G ;
TROWBRIDGE, IS ;
WOOLSTON, RE ;
MASON, DY .
JOURNAL OF CLINICAL PATHOLOGY, 1983, 36 (05) :539-545